台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    85.7
  • 漲跌
    ▲0.9
  • 漲幅
    +1.06%
  • 成交量
    82
  • 產業
    上市 生技醫療類股▼0.22%
  • 353人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
旭富 (4119)籌碼相關-群益金鼎-東湖 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

群益金鼎-東湖 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/22185.2000.0085.7012720.37%
2024/12/311090.0500.0090.60102474.05%
2024/12/0900.00195.8093.40-1224-0.44%
2024/12/0400.00197.7097.80-1216-0.46%
2024/12/0300.001097.7597.80-10216-4.61%
2024/11/2800.000.195.0095.00-0.1197-0.05%
2024/11/2500.001098.0597.60-10187-5.34%
2024/11/21297.6000.0098.0021781.12%
2024/11/20098.20197.6097.80-1172-0.58%
2024/11/19096.0000.0096.1001550.00%
2024/11/18195.9000.0096.0011510.66%
2024/11/12094.0000.0094.3001230.00%
2024/08/06287.7500.0088.9022180.92%
2024/07/18292.3000.0092.7021991.00%
2024/07/17692.8700.0092.6061963.06%
2024/07/16292.3000.0092.7021971.01%
2024/07/15692.60192.0092.8052022.47%
2024/07/1100.00191.8091.80-1203-0.49%
2024/06/18190.2000.0090.4012060.49%
2024/06/131.590.2300.0090.001.52120.71%
2024/06/114.490.8500.0090.204.42142.04%
2024/06/05292.60192.7092.9012200.45%
2024/06/0400.00792.7092.50-7228-3.06%
2024/05/240.191.2500.0091.900.12330.06%
2024/05/23191.6000.0091.3012350.42%
2024/05/21292.30192.6092.1012350.42%
2024/05/16491.5500.0092.5042251.78%
2024/05/15291.2000.0091.5022220.90%
2024/05/14191.20191.2091.2002290.00%
2024/05/1300.00192.0091.80-1232-0.43%
2024/05/10290.3500.0090.9022400.83%
2024/04/22086.0000.0086.5002540.00%
2024/04/17688.5300.0088.4062492.40%
2024/04/12688.4300.0088.5062532.37%
2024/04/09288.9000.0088.9022610.77%
2024/04/02388.9300.0088.6032591.16%
2024/03/2800.00088.4088.3002580.00%
2024/03/27088.4000.0087.5002590.00%
2024/03/22087.7000.0087.6002650.00%
2024/03/18187.1000.0086.9012840.35%
2024/03/150.187.3000.0087.400.12850.03%
2024/02/20191.0000.0091.0012840.35%
2024/02/15189.7000.0089.9012930.34%
2024/02/05391.4700.0091.1032911.03%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章